Disclosure Information

Financial disclosure information is current as of January 2015 and forward. Information is limited to financial relationships with commercial entities that have products in the field of hepatitis C. AASLD defines a direct financial relationship requiring disclosure as a compensated relationship with a company, by an individual, that should generate an IRS Form W2-1099.

Current Chairs

Andrew I. Aronsohn, MD

Personal Financial Relationships: None

Institutional Research: None

Updated: 03/01/2025

Debika Bhattacharya, MD

Personal Financial Relationships: None

Institutional Research: Dr. Bhattacharya was awarded research grants, paid to her institution, from Gilead Sciences Inc.

Updated: 03/01/2025

Vincent Lo Re, MD, MSCE

Personal Financial Relationships: None

Institutional Research: None

Updated: 03/01/2025

Jennifer C. Price, MD, PhD

Personal Financial Relationships: None

Institutional Research: Dr. Price was awarded research grants, paid to her institution, from AbbVie, Cepheid, Gilead Sciences Inc., Merck & Co Inc., and Zydus. Spouse has interest in stock that is independently managed in AbbVie, Bristol-Myers Squibb, Johnson and Johnson, Merck.

Updated: 03/01/2025

Current Panel Members

Matthew J Akiyama, MD, MSc

Personal Financial Relationships: None

Institutional Research: None

Updated: 03/01/2025

Jordan J. Feld, MD, MPH

Personal Financial Relationships: Dr. Feld serves as a scientific consultant to Precision Biosciences, Vir, Roche, GlaxoSmithKline, Gilead, Bluejay Therapeutics, AbbVie, Aligos Therapeutics.

Institutional Research: Dr. Feld was awarded research grants paid to his institution from AbbVie, Atea Pharmaceuticals, Gilead, GlaxoSmithKline, Roche, and Vir.

Updated: 03/01/2025

Theo Heller, MD

Personal Financial Relationships: None

Institutional Research: None

Updated: 03/01/2025

H. Nina Kim, MD MSc

Personal Financial Relationships: None

Institutional Research: None

Updated: 03/01/2025

Tatyana Kushner, MD, MSCE

Personal Financial Relationships: Dr. Kushner serves as a consultant for Eiger, Gilead, Ipsen, Madrigal, and Mirum

Institutional Research: Dr. Kushner received research grants, paid to her institution, from Gilead, Icahn School of Medicine at Mount Sinai

Updated: 03/01/2025

Joseph K. Lim, M.D.

Personal Financial Relationships: None

Institutional Research: Dr. Lim received research grants, paid to his institution from Eiger, Gilead, Intercept, Pfizer, TARGET PharmaSolutions, and Viking

Updated: 03/01/2025

Benjamin P. Linas, MD, MPH

Personal Financial Relationships: None

Institutional Research: None

Updated: 03/01/2025

Michelle T. Martin, PharmD, FCCP, BCPS, BCACP

Personal Financial Relationships: None

Institutional Research: None

Updated: 03/01/2025

Natasha Martin, DPhil

Personal Financial Relationships: None

Institutional Research: Dr. Martin was awarded research grants, paid to her institution, from AbbVie and Gilead.

Updated: 03/01/2025

Ponni Perumalswami, MD

Personal Financial Relationships: None

Institutional Research: None

Updated: 03/01/2025

Gloria Searson, ACSW

Personal Financial Relationships: None

Institutional Research: Ms. Searson's organization was awarded grants from AbbVie, Inc., Gilead Sciences, Inc, and Merck & Co, Inc.

Updated: 03/01/2025

Norah A. Terrault, MD

Personal Financial Relationships: None

Institutional Research: Dr. Terrault was awarded research grants, paid to her institution, from NIH, Gilead Sciences, GSK, Roche-Genentech, Helio Health, Durect Corp., Eiger Pharmaceuticals, Madrigal.

Updated: 03/01/2025